Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists uncover novel role for estrogen in bone marrow

01.12.2003


Scientists have discovered a new role for estrogen in maintaining health. Drs. Yuka Nagata and Kazuo Todokoro report in the December 1 issue of Genes & Development that the most abundant form of naturally occurring estrogen, estradiol, triggers the formation of blood platelet cells. This discovery has important clinical implications for the treatment of conditions associated with altered platelet counts, like anemia, certain leukemias, and even chemotherapy.



Blood is composed of 3 cell types: red blood cells, white blood cells, and platelets. Platelets circulate in the bloodstream to facilitate clotting and halt bleeding. Platelets are derived from a specialized bone marrow cell called a megakaryocyte. A mature megakaryocyte extends long cytoplasmic processes (termed proplatelets) from its cell surface that, in one of the most dramatic morphological changes known to cell biologists, simultaneously fragments into thousands of new platelet cells.

Dr. Nagata and colleagues set out to identify the cellular signal of this remarkable event. Previous work identified a gene regulator (what scientists refer to as a transcription factor) named p45 NF-E2 as being expressed in megakaryocyte cells and required for proplatelet formation. However, the target(s) of p45 NF-E2 were, until now, unknown.


Dr. Nagata found that the 3b-HSD gene is normally turned-on by p45 NF-E2 during megakaryocyte development. 3b-HSD encodes an enzyme that regulates all steroid hormone biosynthesis. Thus, Dr. Todokoro and colleagues explored which steroid hormones are produced in megakaryocyte cells. Much to their surprise, they found estrogen.

Dr. Nagata and colleagues determined that 3b-HSD induces the production of estrogen, in the form of estradiol, in both male and female megakaryocyte cells. Further work demonstrated a crucial role for estradiol in proplatelet formation, as evidenced by their finding that the addition of exogenous estradiol increased proplatelt formation by more than %50, while the inhibition of estradiol receptors blocked proplatelet formation in live mice.

Taken together, this work by Dr. Nagata and colleagues delineates a genetic mechanism for regulating the formation of blood platelets: The p45 NF-E2 transcription factor turns on 3b-HSD gene expression, leading to the synthesis of estradiol and the subsequent activation of proplatelet formation. Such insight will enable researchers and clinicians to devise therapeutic strategies to manipulate this process, either to increase or decrease proplatelet formation.

The authors suggest that patients suffering from low platelet counts, such as those with anemia, bone marrow abnormalities, or undergoing chemotherapy, may benefit from the administration of estradiol and/or a 3b-HSD activator, as an alternative to blood transfusions to increase platelet levels. Conversely, patients with abnormally high platelet counts, who are prone to forming clots and therefore at an increased risk for strokes, heart attacks, or even miscarriage (ie. from placental clots) would be candidates for drugs designed to specifically block 3b-HSD or estradiol receptors to effectively normalize their platelet levels.

Heather Cosel | EurekAlert!
Further information:
http://www.cshl.org/

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>